Business Context and Reporting Period
This Form 8-K was filed by AmerisourceBergen Corporation (now Cencora, Inc.) on March 18, 2016. The report discloses the full exercise of unregistered equity warrants issued to affiliates of Walgreens Boots Alliance, Inc. (WBA) pursuant to a 2013 Framework Agreement.
Key Financial Metrics and Transaction Details
- Transaction Type: Full exercise of Warrant 1A and Warrant 1B.
- Shares Issued: 22,696,912 shares of Common Stock.
- Exercise Price: $51.50 per share.
- Cash Proceeds: $1,168,890,968 received by the Company.
- Post-Transaction Share Count: 225,424,994 shares outstanding (based on March 16, 2016 data).
Material Changes
The primary material change is the increase in outstanding common stock and the corresponding cash inflow resulting from the warrant exercise. The filing notes that these shares were issued in reliance on the Section 4(2) exemption from registration under the Securities Act of 1933.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance, management commentary on future outlook, or specific risk factors beyond the standard disclosure that the report does not constitute an offer to sell securities in jurisdictions where such an offering would be unlawful.
Investor Verification Checklist
- Verify the updated total share count and potential dilution impact on earnings per share.
- Confirm the utilization of the $1.17 billion in cash proceeds.
- Review the terms of the 2013 Framework Agreement and Shareholders Agreement for any remaining obligations between AmerisourceBergen and WBA.
- Check subsequent filings for any changes in WBA's ownership percentage following this issuance.